Recent Updates
Recently added Catalysts
WAT Positive Sentiment Score: 85/100

Waters Corporation Completes Acquisition of Light Scattering Leader Wyatt Technology Milford, MA.

Key Takeaway: Waters Corporation has completed the acquisition of Wyatt Technology, a leader in light scattering instruments and services. This move is expected to enhance Waters' capabilities in bioanalytical characterization, particularly for new modalities like cell and gene therapies, projected to have a $1.8 billion market. The transaction is anticipated to be immediately accretive to revenue and earnings, while generating significant revenue synergies over the next five years. Dr. Udit Batra, President and CEO of Waters, noted the acquisition as a milestone for advancing the company's growth strategy.

Market Sentiment Analysis

POSITIVE FACTORS

  • The acquisition of Wyatt Technology will accelerate Waters' growth in bioanalytical characterization.
  • The deal is expected to generate over $70 million in annual revenue synergies by the fifth year.
  • The transaction is anticipated to be accretive to Waters' revenue growth and adjusted earnings per share starting Q1 2024.

Full Press Release Details

Corporation Completes Acquisition of Light Scattering Leader Wyatt Technology
Milford, MA., May 16, 2023 Waters Corporation (NYSE:WAT) today announced it has completed its acquisition of Wyatt Technology, a pioneer and well-recognized leader in innovative light scattering and field-flow fractionation
instruments, software, accessories, and services.
With more than 80% of its rapidly growing revenues tied to large molecule applications, Wyatt
accelerates Waters ability to build a high-growth business in bioanalytical characterization for new modalities. This includes cell and gene therapies, which represents a significant opportunity with a $1.8 billion total addressable
market and 10-12% projected annual growthi. Wyatt s highly complementary analytical technologies, together with Waters global reach and expertise
in simplifying sophisticated techniques for high-volume applications, positions Waters to better serve the fast-growing needs of its global customers.
We are pleased to complete the acquisition of Wyatt, which is a significant milestone for Waters as we advance our strategy to accelerate value creation
and generate faster growth, said Dr. Udit Batra, President and CEO, Waters Corporation. With Wyatt, we are even better positioned to solve our customers critical challenges with differentiated bioanalytical characterization
techniques. We welcome the Wyatt team to Waters, and look forward to facilitating a smooth integration process and working together to deliver an unmatched set of bioanalytical characterization solutions to our global customers.
As previously announced, the transaction is expected to be immediately accretive to Waters revenue growth and margin profile. Additionally, Waters
expects to generate over $70 million in annual revenue synergies by the fifth year following transaction close. The transaction is also expected to be accretive to Waters adjusted earnings per share beginning in Q1 2024 and to deliver a
high single-digit plus adjusted return on invested capital in year five, net of tax.
About Waters Corporation
Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis
innovations serving the life, materials, and food sciences for over 60 years. With more than 8,200 employees worldwide, Waters operates directly in 35 countries, including 14 manufacturing facilities, and with products available in more than 100
About Wyatt Technology
Wyatt Technology is the recognized leader in light scattering instrumentation and software for determining the absolute molar mass, size, charge, and
interactions of macromolecules and nanoparticles in solution. More than 40 years ago, Wyatt Technology s scientists invented the very first commercial light scattering detectors incorporating lasers as their light source. Our customers span the
breadth of pharmaceutical and biotech industries, government labs, medical devices, academic institutions, and companies developing chemicals, cosmetics, foods, and beverages. With a staff composed of approximately 25% Ph.D. scientists, and many
more dedicated and experienced support personnel, Wyatt s goal is to delight its customers with the best products, training, customer support, and service available in the industry.
Forward-Looking Statements
In addition to historical
facts or statements of current condition, this press release contains forward-looking statements. Forward-looking statements provide each of Waters and Wyatt s current expectations or forecasts of future events. These may include
statements regarding the timing and success of integration efforts post-closing, expectations or ability to realize commercial success, the impact of this transaction, if successful, on Waters business, anticipated progress on Waters
research programs, development of new analytical instruments and associated software or consumables, manufacturing development and capabilities, market prospects for its products, sales and earnings guidance, and other statements regarding matters
that are not historical facts. You may identify some of these forward-looking statements by the use of words in the statements such as anticipate, estimate, expect, project, intend,
plan, believe, or other words and terms of similar meaning. Waters performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic,
regulatory, and political conditions affecting the analytical technology industry, as well as more specific risks and uncertainties facing Waters such as those set forth in its reports on Form 8-K, 10-Q, and 10-K filed with the U.S. Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be
incorrect. Therefore, you should not rely on any such factors or forward-looking statements. Furthermore, Waters does not intend to update publicly any forward-looking statement, except as required by law. The U.S. Private Securities Litigation
Reform Act of 1995 permits this discussion.
Waters is a trademark of Waters Corporation.
Director, Investor Relations
Senior Director, Public Relations

Frequently Asked Questions

What recent acquisition has Waters Corporation completed?

Waters Corporation has acquired Wyatt Technology, a leader in light scattering.

What is the significance of Wyatt Technology for Waters?

Wyatt Technology enhances Waters' bioanalytical capabilities, especially for large molecules.

How will the acquisition impact Waters' revenue?

The transaction is expected to be accretive to revenue growth and margins immediately.

What are the projected revenue synergies from this acquisition?

Waters anticipates generating over $70 million in annual revenue synergies by year five.

When will the acquisition affect Waters' earnings per share?

The acquisition is expected to positively impact adjusted earnings per share starting Q1 2024.

Last updated: May 16, 2023